Single-cell transcriptomic changes in oligodendroglial lineage cells derived from Parkinson's disease patient-iPSCs with LRRK2-G2019S mutation
Nasser Karmali, Wiebke Kessler, Mohammad Dehestani, Wenhua Sun, Layla DrweshiD, Polina VolosiD, Stanislav Tsitkov, Ashutosh DhingraiD, Christian ThomasiD, Salvador Rodrı́guez-Nieto, Julia Tietz, David SchafflickiD, Noémia FernandesiD, Julia Fitzgerald, Ernest FraenkeliD, Thomas GasseriD, Nisha Mohd RafiqiD, Tanja KuhlmanniD, Vikas BansaliD
Abstract
Despite extensive research, the contribution of the LRRK2 p.G2019S mutation to Parkinsons disease (PD) remains unclear. Recent findings indicate oligodendrocytes (ODCs) and their progenitors are vulnerable in PD pathogenesis. Notably, oligodendrocyte precursor cells (OPCs) exhibit high endogenous expression of LRRK2. We induced PD patient-iPSCs with the LRRK2 p.G2019S mutation into oligodendroglial lineages and performed single-cell RNA sequencing. Cell type composition analysis revealed an increase in OPCs, proliferating OPCs and ciliated ependymal cells in LRRK2 lines, all of which are characterized by LRRK2 expression. Differential expression analysis revealed transcriptomic changes in several pathways, including down-regulation of genes related to myelin assembly in ODCs, semaphorin-plexin pathway in OPCs, and cilium movement in proliferating OPCs. Cell-cell communication analysis identified significant alterations in several signaling pathways including a deactivation of PSAP signaling and an activation of MIF signaling in LRRK2 lines. Additionally, we observed an overall increase in SEMA6 signaling communication in LRRK2 cell lines; however, OPCs derived from these LRRK2 lines specifically lost SEMA6 signaling due to a down-regulation of SEMA6A and PLXNA2. Pseudotemporal trajectory analysis revealed that SHH had significantly altered expression along the pseudotime, accompanied by higher expression levels in LRRK2 lines. We propose that dysfunctional semaphorin-plexin signaling, along with cilia movement and SHH signaling, might represent early events in PD pathology.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 45th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- LRRK2 G2019S variant is associated with transcriptional changes in Parkinson's disease human myeloid cells under proinflammatory environment
Elisa Navarro, Anastasia G. Efthymiou, … Towfique Raj·Journal of NeuroinflammationPeer-reviewed·Aug 8, 2026
- Oligodendroglia vulnerability in the human dorsal striatum in Parkinson's disease
Juan M. Barba-Reyes, Lisbeth Harder, … Ana B. Muñoz‐Manchado·Acta NeuropathologicaPeer-reviewed·May 5, 2025
- Single-cell resolution uncovers cell type-specific dysregulation in Parkin-deficient neuron-microglia co-cultures
Evelyn Knappe, Kristian Händler, … Philip Seibler·bioRxiv·Mar 27, 2026
- LRRK2 G2019S mutation suppresses differentiation of Th9 and Treg cells via JAK/STAT3
Ningbo Zheng, Roshni Jaffery, … Weiyi Peng·bioRxiv·Feb 28, 2024
- The Parkinsons disease associated Leucine-rich repeat kinase 2 affects expression of Transferrin receptor 1 and phosphorylation of key signaling proteins in human iPSC-derived dopaminergic neurons
Natalja Funk, Felix Knab, … Saskia Biskup·bioRxiv·May 6, 2025
- Lysosomal Glucocerebrosidase is needed for ciliary Hedgehog signaling: A convergent pathway to Parkinsons disease
Sreeja V. Nair, Ebsy Jaimon, … Suzanne R. Pfeffer·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 30, 2025